Concord Biotech Share Price
CONCORDBIO
₹2,129.35+₹4.15 (0.20%) TodayLast updated on 20 Dec, 2024 | 15:51 IST
Concord Biotech Share Price Chart
Please wait...
About Concord Biotech
Concord Biotech Financials
Market cap ₹22,276 Crs | Open ₹2,150.00 | Close ₹2,125.20 |
Circuit range ₹2,555.20 - ₹1,703.50 | Day range ₹2,096.05 - ₹2,162.95 | Year range ₹1,327.05 - ₹2,664.00 |
Volume 55,257 | Avg. traded ₹2,130.66 | Revenue (12m) ₹1,086 Crs |
Concord BiotechConcord Biotech Limited is an India-based research and development driven biopharma company. The Company is engaged in the research and development, manufacturing, marketing, and selling of pharmaceutical products. The Company manufactures active pharmaceutical ingredients (API) through fermentation and semi-synthetic process and finished formulations. The Company’s offerings span both bio-pharmaceutical APIs and formulations across therapeutic areas like immunosuppressants oncology, anti-infectives nephrology, and critical care. Its portfolio also includes fermentation-based APIs in anti-bacterial, anti-fungal, and other therapeutic segments. Its API products include Mycophenolate Mofetil, Mycophenolate Sodium, Cyclosporine, Sirolimus, Pimecrolimus, Voclosporin, Mupirocin, Mupirocin Calcium, Vancomycin Hydrochloride, Teicoplanin, Polymyxin B Sulfate, Fidaxomicin, Anidulafungin. Its API products under development include Daptomycin, Epirubicin, Idarubicin, and Pirarubicin.
Concord Biotech Key indicators
52 week high ₹2,664.00 | 52 week low ₹1,327.05 | P/E ratio 57.49 |
P/B ratio 14.46 | ROE 21.63% | ROCE 28.89% |
Dividend yield 0.4% | Debt/Equity ratio | EPS 29.13 |
Learn more
Sector
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
67%
Hold
33%
Sell
0%
This analysis is based on the reviews of 3 experts in the last 7 days
Concord Biotech Fundamentals
Concord Biotech Financial Ratios
Operating profit margin45.82% | Net profit margin29.97% |
ROE21.63% | ROA18.96% |
ROCE28.89% |
Quick ratio4.84 | Current ratio6.3 |
Interest coverage129.52 | Asset turnover0.63 |
Debt to Equity0 |
P/E ratio57.49 | P/B ratio14.46 |
EV / EBITDA34.08 | |
Dividend yield0.4% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)Learn more
Cash flow
All values are in ₹ Crores (Cr)Learn more
Balance sheet
All values are in ₹ Crores (Cr)Total assets
Total liabilities
Learn more
Concord Biotech Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Fri, Dec 20 2024 | ₹2,150.00 | ₹2,129.35 | |
Thu, Dec 19 2024 | ₹2,130.35 | ₹2,125.20 | -2.22% |
Wed, Dec 18 2024 | ₹2,078.00 | ₹2,173.35 | |
Tue, Dec 17 2024 | ₹2,103.50 | ₹2,059.10 | -2.11% |
Mon, Dec 16 2024 | ₹2,117.45 | ₹2,103.50 | -0.37% |
Fri, Dec 13 2024 | ₹2,139.85 | ₹2,111.40 | -1.45% |
Thu, Dec 12 2024 | ₹2,199.35 | ₹2,142.45 | -2.38% |
Wed, Dec 11 2024 | ₹2,124.80 | ₹2,194.70 |
Events
Corporate actions
Dividend • ₹8.75/share
Ex date 21 Jun 2024
Learn more
More
Popular Stocks
Concord Biotech News
FAQs on Concord Biotech
What is the Concord Biotech share price today?
Concord Biotech share price is ₹ 2,129.35 today.
What is today’s high & low share price of Concord Biotech?
Concord Biotech share price high: ₹ 2,162.95 and low: ₹ 2,096.05
What is the Concord Biotech share price high and low in the last 52 weeks on the NSE?
52 Week share High Price is ₹ 2,664.00 and Low Price is ₹ 1,327.05
What is the Concord Biotech Stock Symbol?
The Concord Biotech Stock symbol is CONCORDBIO.
Can I buy Concord Biotech shares on Holidays?
No, shares of Concord Biotech or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Concord Biotech shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.